NEW YORK (GenomeWeb News) – Agilent Technologies today announced a collaboration with Gachon University of Medicine and Science in South Korea to use proteomics and glycoproteomics for biomarker discovery.

Under a memorandum of understanding, the laboratory at the university's College of Pharmacy will serve as Agilent's beta test site for complete glycoproteomics and biomarker discovery workflow solutions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.